Longevity, decoded.
One protocol at a time.
Discover How SkinStim Can Enhance Your Health and Beauty
Lionheart Health Expands Bioelectric Regenerative Medicine Platform to Target TBX20, PITX2, MEIS1 and pro-ANP/NPPA
Company plans research program combining precisely controlled bioelectric signaling, regenerative protein-expression targets, Klotho-expressing cells and nutrient...
Read more
Leonhardt Ventures and Lionheart Health File Provisional Patent Application for Bioelectric Hair Repigmentation Platform
Proposed system combines programmable bioelectric protein-expression signaling with regenerative biologics intended to support restoration of natural...
Read more
Lionheart Health Shares VascuStim™ Accelerated Wound-Healing Study Results and Launches New Multi-Modality Studies
Program builds on decades of bioelectric and regenerative-medicine research and is advancing an investigational multi-modality protocol...
Read more
Lionheart Health Announces Clinical Results Supporting Brain Band™ and BodStim™ Programs for Brain Health and Healthy Aging
Clinical programs combine bioelectric signaling, neuromuscular stimulation and regenerative-health technologies designed to support cognition, physical performance...
Read more
Lionheart Health Announces Positive Clinical Trial Results for ErectiStim™ Male Sexual Wellness Bioelectric Therapy Platform
Five Clinical Studies Demonstrate Improvements in Male Sexual Wellness and Erectile Function as Lionheart Expands into...
Read more
Lionheart Health Announces Encouraging BladderCell™ Clinical Results and Expands Regenerative Bladder & Pelvic Health Platform with B-Alive™, PelvicStim™, and Next-Generation Implantable Bioelectric Therapy
Clinical Program in Brazil Demonstrates Encouraging Improvements in Bladder Function While Company Advances Wearable, Regenerative, and...
Read more
The “Arterial Cement” Problem: A Multi-Modal Strategy for Healthier Blood Pressure and Vascular Aging
Why Lionheart Health’s PressureStim™, Electro-Acupuncture, BodStim™ Exercise and Klotho-Up USA Program Target More Than a Number...
Read more
Leonhardt Ventures Announces Provisional Patent Application for Combination Osteoarthritis Therapy Featuring Pentadeca Arginate (PDA+) Licensed to Lionheart Health’s OrthoStim™ Platform
New investigational study arm to evaluate multimodality regenerative approach for joint health, mobility, inflammation, and healthy...
Read more
Lionheart Health Announces Positive Pilot Clinical Trial Results for PressureStim™ Investigational Wellness Technology
Independent randomized clinical study demonstrates significant blood pressure reductions with sensory electrical stimulation applied over the...
Read more
Lionheart Health Launches New Hepatocyte Growth Factor (HGF) Studies as Part of its Klotho-Up™ Longevity Protocol
IRVINE, California — July 28, 2026 — Lionheart Health, Inc. today announced the launch of new clinical and translational...
Read more
Leonhardt Ventures LLC, Lionheart Health, and CancerCell Prepare Provisional Patent Application for Bioelectric Expression of Thymulin Across Multiple Therapeutic Applications
Huntington Beach, California – July 28, 2026 — Leonhardt Ventures LLC, in collaboration with Lionheart Health, Inc. and CancerCell, Inc., today...
Read more
The Next Decade of Healthy Longevity: Why Technology May Become the Primary Driver of Healthspan Extension
A Forward-Looking Perspective Over the past century, improvements in life expectancy have been driven primarily by...
Read more